In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. Pancreatic Cancer, Pancreas, Clinical Trials, Drugs (Pharmaceuticals), Tumors, Research Read More
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
